3 cloningpowerpoint
DESCRIPTION
The aim of this exercise is to work together, as a group, to design a strategy for the production of a medically important protein using recombinant DNA technologyTRANSCRIPT
The aim of this exercise is to work together, as a group, to design a strategy for
the production of a medically important protein using recombinant DNA
technology. You are provided with a series of cards. These begin with a general
introduction (cards 2-3) and the outline of the characteristics of the three
particular proteins (cards 4-6). After choosing which protein you want to
produce you should work through the remaining cards and produce a strategy
after discussion in the group. The cards give full details of the procedures
involved in cloning and expressing a gene. At the end of each card you are
given a choice as to what to do next. Some of your decisions will lead to dead
ends as you may have done something incorrectly, whilst others will eventually
lead to the production of your protein. You must also consider the fact that for
the purpose of simplicity it is assumed that all techniques work with 100%
efficiency - this is not the case in real life!!!
Aim
1
Go to 2
Introduction
2
Recombinant DNA technology has proven to be extremely useful in the
treatment of several medical disorders. For example, the human insulin gene
has been cloned into a plasmid vector and expressed in E. coli. Large amounts
of insulin can then be produced and used to treat diabetes. Other examples of
proteins produced by recombinant methods are growth factors, blood clotting
agents and vaccines. Producing proteins by recombinant methods can be
cheaper and safer than previously used methods. Protein extracted from
human or animal sources may be contaminated e.g. with viruses. Moreover,
those sources may be in short supply.
Go to 3
Introduction
The first step in producing a medically important protein is to clone the wild
type gene. The gene must then be transformed into a host cell where it can be
expressed, and then the gene product purified. The most popular expression
systems are E. coli, yeast and cultured mammalian cells. Each host has its own
pros and cons which must be considered when choosing a system for the
expression of a particular protein. For example, many eukaryotic proteins have
to undergo complex post-translational modifications in order to become
biologically active. Many of these processes are specific to higher
eukaryotic cells, and do not take place in E. coli or yeast.
3
Go to 4
Protein 1: Somatostatin
Somatostatin is a simple 14 amino acid peptide hormone which inhibits the
secretion of other peptide hormones, such as growth hormones, insulin and
glucagon. It is synthesised in several tissues including the brain, hypothalamus
and pancreatic islets. Somatostatin is important in the treatment of a variety of
human growth disorders, including acromegaly, a condition characterised by
uncontrolled bone growth. The amino acid sequence of this protein is known
and antibodies are available. The gene encoding somatostatin is 1542bp in
length. This contains the coding region, a signal sequence for secretion and a
single intron, which is present in the signal sequence.
4
Go to 5
Learn more about Somatostasin
Protein 2: hEFG
Human epidermal growth factor (hEGF) is a single chain polypeptide
consisting of 53 amino acids. It is synthesised in the duodenum and the
salivary glands, and small amounts of the protein can be isolated in urine,
thus the amino acid sequence is known and antibodies can be produced. This
peptide hormone is a promoter of epithelial cell proliferation, and inhibits
gastric acid secretion. Thus, it may be possible to use recombinantly
produced hEGF in the treatment of duodenal ulcers.
5
Go to 6
Learn more about duodenal ulcers
Protein 3: Factor IX
Factor IX is a 415 amino acid plasma glycoprotein which has an essential role
in blood clotting. Production of the protein is vital for the treatment of
haemophilia. Factor IX is synthesised in liver hepatocytes where it undergoes
three distinct types of post-translational modification. These modifications are
very complex and very specialised. The active protein can be purified in small
amounts from blood plasma, therefore the amino acid sequence is known and
antibodies can be produced. The gene encoding Factor IX is 34kb in length.
The gene consists of 8 exons and 7 introns, which make up 90% of the
sequence. Thus it is an enormously complicated gene.
6
Learn More about Factor IX
Make a note of the protein you have chosen and Go to 7
Cloning the Gene
7
You now know some of the specific characteristics of your chosen protein
which will help you in choosing the best host, vectors and techniques
necessary for producing your recombinant protein. You must now clone your
gene. This is done by inserting a mixture of DNA fragments, one of which will
contain the gene of interest, into separate vector molecules. These molecules
are then introduced into E. coli by transformation. Usually only one recombinant
molecule will go into each cell. Therefore, the gene of interest can be identified
by screening the resultant colonies. Once the gene has been identified, it can
be subcloned into an appropriate vector for transformation into either yeast or
mammalian cells dependent on requirements.
Go to 8
Choice of Library
8
To clone your gene you may use either a cDNA library or a genomic library.
To learn about cDNA libraries click here
To learn about genomic libraries click here
To use a cDNA library click here
To use a genomic library click here
cDNA library
9
Complementary DNA is obtained by copying mRNA. The cDNA gives an exact
copy of the gene's coding sequences, but lacks introns and transcription
signals. One advantage of using mRNA to obtain your DNA sequences, is that
any given cell type expresses only a subset of its chromosomal genes.
Therefore, if you obtain your mRNA from a source which expresses your gene
of interest, there will be a higher chance of identifying that specific gene.
For more details on constructing a cDNA library click here.
To return click here.
Genomic library
10A genomic library is a collection of clones sufficient in number to include all the
genes of a particular organism. The larger the organism, the bigger the library.
Therefore, bacterial and yeast genomic libraries are commonplace, and it is
relatively easy to identify a given gene. However animal libraries are so large,
due to the enormous size of the genomes, that it is a mammoth task to identify
any one gene.
Genomic libraries are prepared by purifying total cell DNA and then making a
partial restriction digest, resulting in fragments that can be cloned into a
suitable vector.
In order to obtain a representative human library, a λ-based vector called a
cosmid is used. Cosmids can be used to clone inserts of up to about 40 kb.
To see a simple diagram showing this process click here.
To return click here.
Source of mRNA
11
mRNA is purified from cells by oligo(dT) cellulose chromatography. The mRNA
molecules bind to the oligo(dT), which is linked to the cellulose column, via their
polyA tails, while the remainder of the RNA species flows through the column.
The bound mRNAs are then eluted from the column. When the mRNA has been
purified, double-stranded DNA must be synthesised.
You must choose one of the following from which to collect mRNA:
Liver hepatocytes which synthesize blood clotting factors
or
Pancreatic Islets which synthesize insulin, glucagon and somatostatin
or
Duodenal cells which synthesize epidermal growth factor.
Make a note of the cell type you have chosen and Go to 12
Primers
12
Most DNA polymerases can function only if the template possesses a
double-stranded region which acts a primer for the initiation of
polymerization. If your template is single-stranded, a synthetic primer must
be added for DNA synthesis to occur. You may choose to use:
1. No primer
2. Oligo(dC)
3. Oligo(dG)
4. Oligo(dT)
5. An oligo synthesised from known amino acid sequence
Make a note of your choice and Go to 17
Oligo(dC)
An oligonucleotide consisting only of cytosine (dC) residues, will anneal via
complementary base pairing to a run of guanosine residues (polyG). A polyG
tail can be added onto the 3' end of a double- or single-stranded DNA / RNA
molecule by terminal deoxynucleotidyl transferase.
13
C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C
Return
Oligo(dG)
An oligonucleotide consisting only of guanosine (dG) residues, will anneal via
complementary base pairing to a run of cytosine residues (polyC). A polyC tail
can be added onto the 3' end of a double- or single-stranded DNA / RNA
molecule by terminal deoxynucleotidyl transferase.
14
G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G
Return
Oligo(dT)
An oligonucleotide consisting only of thymidine (dT) residues, will anneal via
complementary base pairing to a run of adenine residues (polyA). A polyA tail
can be added onto the 3' end of a double- or single-stranded DNA / RNA
molecule by terminal deoxynucleotidyl transferase. A polyA tail is found
naturally at the 3’ end of most RNA molecules.
15
T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T
Return
Oligo (amino acid sequence)
Oligonucleotides can be synthesised which correspond to a specific DNA
sequence. The DNA sequence may already be known, or can be determined
from a known amino acid sequence, although the degeneracy of the genetic
code must be taken into consideration when designing an oligonucleotide from
an amino acid sequence.
16
G-C-A-T-A-G-T-C-C-A-G-C-G-T-T-A-C-T-C-T-G-A-A-T-C-A-C-G
Return
DNA polymerases
DNA polymerases are enzymes that synthesize a new strand of DNA
complementary to an existing template. Most polymerases can function only if
the template possesses a double-stranded region which acts as a primer for
initiation of polymerisation. There are a range of different polymerases each
with different characteristics.
17
5' - A-T-G-C-A-A-T-G-C-A- 3' --- TEMPLATE 3'-C-G-T- 5' --- PRIMER
You may choose to use:
Klenow fragment of DNA polymerase I
or
Reverse transcriptase
or
DNA polymerase I
Make a note of your choice and then check first strand synthesis here.
Klenow fragment
18
The Klenow fragment of DNA polymerase I contains the polymerase function of
the enzyme. It can only use DNA as a template. Since it does not contain the 5'
- 3' exonuclease activity of DNA polymerase I, Klenow can be used to
synthesise a complementary DNA strand on a single-stranded template without
degrading the cDNA.
Learn more about the Klenow fragment of DNA polymerase I
Return
Reverse Transcriptase
19
Reverse transcriptase is an enzyme involved in the replication of several kinds
of virus. Reverse transcriptase is unique in that it can use RNA as a template
as well as DNA. Like other DNA polymerases, reverse transcriptase requires a
primer.
Learn more about the reverse transcriptases
Return
DNA polymerase I
20
DNA polymerase I has a polymerase function and nuclease activity. The
enzyme attaches to a short single stranded region (nick) in a mainly double-
stranded DNA molecule, then synthesises a complementary DNA strand,
degrading the existing strand as it proceeds. It degrades single-stranded DNA.
Learn more about DNA polymerase I
Return
First strand synthesis
In Reaction 2 one of the dNTP's will be radioactive. DNA synthesis will result in the
radiolabelled dNTP being incorporated into the DNA. A sample of the radiolabelled
reaction can then be run on a 1.4% alkaline agarose gel. Autoradiography is then used
to detect DNA synthesis.
To check DNA synthesis parallel reactions are set up.
Reaction 1: experimental - the sample which will go on to the 2nd strand synthesis
Reaction 2: test sample - to check efficiency of 1st strand synthesis.
21
14 (25)None(unless added polyC /polyG tail to template)
Reverse transcriptaseoligo(dG) /oligo(dC)
24DNA synthesisReverse transcriptaseoligonucleotide
25Correct DNA synthesisReverse transcriptaseoligo(dT)
19NoneDNA polymerase IAny
19NoneKlenowAny
14NoneAnyNone
Go toDNA synthesis ?Polymerase ?Primer ?
ResultsConditions
14 (25)None(unless added polyC /polyG tail to template)
Reverse transcriptaseoligo(dG) /oligo(dC)
24DNA synthesisReverse transcriptaseoligonucleotide
25Correct DNA synthesisReverse transcriptaseoligo(dT)
19NoneDNA polymerase IAny
19NoneKlenowAny
14NoneAnyNone
Go toDNA synthesis ?Polymerase ?Primer ?
ResultsConditions
Click here
Click here
Click here
Click here
Click here
Click here
No DNA synthesis
22
First strand synthesis requires the use of an oligo(dT) primer.
To try again click here
To proceed click here
Oligo(dT)
An oligonucleotide consisting only of thymidine (dT) residues, will anneal via
complementary base pairing to a run of adenine residues (polyA). A polyA tail
can be added onto the 3' end of a double- or single-stranded DNA / RNA
molecule by terminal deoxynucleotidyl transferase. A polyA tail is found
naturally at the 3’ end of most RNA molecules.
23
T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T
Return
No DNA synthesis
24
First strand synthesis requires the use of a reverse transcriptase, because the template is
RNA.
To try again click here
To proceed click here
Reverse Transcriptase
25
Reverse transcriptase is an enzyme involved in the replication of several kinds
of virus. Reverse transcriptase is unique in that it can use RNA as a template
as well as DNA. Like other DNA polymerases, reverse transcriptase requires a
primer.
Learn more about the reverse transcriptases
Return
cDNA synthesis
It must be noted that if you used an oligonucleotide primer, which was
complementary to mRNA sequences at the 5' end of the molecule, then the
cDNA may be missing some of the 5' untranslated region.
To try again with a different primer click here
To proceed click here
26
Second strand synthesis
27
You may:
Proceed immediately with second strand synthesis.
or
Denature the hybrid molecule with alkali.
or
Partially degrade the RNA strand with RNase H
You now have RNA-DNA hybrid molecules. You must now synthesise the 2nd
DNA strand.
DNA G-C-G-G-T-A-G-A-T-G-C-A-G-A-A-RNA C-G-C-C-A-U-C-U-A-C-G-U-C-U-U-
Alkali denature
28
You may denature your RNA-DNA hybrid molecules with an alkali which also
hydrolyses the RNA strand. This will then give you single-stranded DNA
molecules. You now need to synthesise the 2nd DNA strand.
If you need a primer select one of:
oligo(dC)
oligo(dG)
oligo(dT)
an oligo synthesized from known amino acid sequence.
Then select a polymerase from:
Klenow fragment of DNA polymerase I
reverse transcriptase
DNA polymerase IMake a note of your choice and then check 2nd strand synthesis here.
Oligo(dC)
An oligonucleotide consisting only of cytosine (dC) residues, will anneal via
complementary base pairing to a run of guanosine residues (polyG). A polyG
tail can be added onto the 3' end of a double- or single-stranded DNA / RNA
molecule by terminal deoxynucleotidyl transferase.
29
C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C-C
Return
30
Oligo(dG)
An oligonucleotide consisting only of guanosine (dG) residues, will anneal via
complementary base pairing to a run of cytosine residues (polyC). A polyC tail
can be added onto the 3' end of a double- or single-stranded DNA / RNA
molecule by terminal deoxynucleotidyl transferase.
G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G-G
Return
31
Oligo(dT)
An oligonucleotide consisting only of thymidine (dT) residues, will anneal via
complementary base pairing to a run of adenine residues (polyA). A polyA tail
can be added onto the 3' end of a double- or single-stranded DNA / RNA
molecule by terminal deoxynucleotidyl transferase. A polyA tail is found
naturally at the 3’ end of most RNA molecules.
T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T
Return
32
Oligo (amino acid sequence)
Oligonucleotides can be synthesised which correspond to a specific DNA
sequence. The DNA sequence may already be known, or can be determined
from a known amino acid sequence, although the degeneracy of the genetic
code must be taken into consideration when designing an oligonucleotide from
an amino acid sequence.
G-C-A-T-A-G-T-C-C-A-G-C-G-T-T-A-C-T-C-T-G-A-A-T-C-A-C-G
Return
33
Klenow fragment
The Klenow fragment of DNA polymerase I contains the polymerase function of
the enzyme. It can only use DNA as a template. Since it does not contain the 5'
- 3' exonuclease activity of DNA polymerase I, Klenow can be used to
synthesise a complementary DNA strand on a single-stranded template without
degrading the cDNA.
Learn more about the Klenow fragment of DNA polymerase I
Return to ‘Alkali denature’
Return to ‘RNase H treatment’
34
Reverse Transcriptase
Reverse transcriptase is an enzyme involved in the replication of several kinds
of virus. Reverse transcriptase is unique in that it can use RNA as a template
as well as DNA. Like other DNA polymerases, reverse transcriptase requires a
primer.
Learn more about the reverse transcriptases
Return to ‘Alkali denature’
Return to ‘RNase H treatment’
35
DNA polymerase I
DNA polymerase I has a polymerase function and nuclease activity. The
enzyme attaches to a short single stranded region (nick) in a mainly double-
stranded DNA molecule, then synthesises a complementary DNA strand,
degrading the existing strand as it proceeds. It degrades single-stranded DNA.
Learn more about DNA polymerase I
Return to ‘Alkali denature’
Return to ‘RNase H treatment’
36
RNase H treatment
You may partially degrade the RNA strand of your RNA-DNA hybrid with
Ribonuclease (RNase) H. This leaves small fragments of RNA associated with
your DNA strand. These fragments of RNA can act as primers.
Select a polymerase from:
Klenow fragment of DNA polymerase I
reverse transcriptase
DNA polymerase I
Make a note of your choice and then check 2nd strand synthesis here.
37
Second strand synthesis
You may check 2nd strand synthesis the same way as 1st strand synthesis.
Conditions Results
Treatment ? Primer ? Polymerase ? DNA synthesis ?
RNase H None Reverse transcriptase (RT)
Incorrect synthesis
None Klenow (K) Incorrect synthesis
None DNA polymerase I (D) Correct DNA synthesis
Alkali None RT / K / D DNA synthesis
Any RT / K / D Correct DNA synthesis
None None / Any RT / K / D None Click here
Click here
Click here
Click here
Click here
Click here
DNA polymerase I is required for successful RNase H treatment. This is because Klenow lacks exonuclease activity and reverse transcriptase will not work unless the RNA strand is fully hydrolysized.
To try again click here
To proceed click here
Incorrect DNA synthesis
37
If a primer is not added to the 1st strand before 2nd strand synthesis, the cDNA
can form a transient self-priming structure in which a hairpin loop at the 3' end
is stabilised by enough base pairing to allow initiation of 2nd strand synthesis.
Once initiated, subsequent synthesis of the 2nd strand stabilises the hairpin
loop. Thus, the resultant double-stranded molecule has the hairpin loop intact,
therefore it has to be removed before ligation can occur. The hairpin loop is
digested with S1 nuclease, however the S1 nuclease treatment can also digest
much of the 5' coding sequences, thus producing an incomplete cDNA.
Hairpin loop
39
To try again click here
To proceed click here
Genomic library
40
Having created a cosmid library and isolated one cosmid which contains your
specific gene, within about 40 kb, you must now sub-clone the insert DNA into
an alternative vector in order to isolate the gene and express the protein.
Proceed
Cloning the gene
41The next step in producing large amounts of protein, is to clone the gene of
interest. Usually the cDNAs or fragments of genomic DNA are inserted into
cloning vectors, which are then transformed into E. coli. E. coli is the organism
used for constructing libraries because of its high transformation efficiency and
simple selection procedures, thus making it possible to screen thousands of
colonies. When the vector carrying the gene of interest is identified, the gene
can be subcloned into the expression vectors of other organisms. These
vectors are then introduced into the appropriate host, where the protein will
eventually be expressed. For simplicity, you will be inserting your
cDNA/genomic DNA directly into shuttle vectors. These are vectors which can
replicate and be selected for in E. coli and one other organism. This means that
you can identify your gene in E. coli, but will not have to sub-clone into an
appropriate expression vector. Therefore you must now decide which host
organism will be suitable for you to express your gene in eventually. Do not
forget to consider your protein's characteristics when choosing your host.
Choose a host
Choosing a host
42
You may choose one of the following to act as your host organism:
E. coli
Yeast
A mammalian cell system
E. coli host
43
Advantages of E. coli a host for the production of heterologous proteins: (1) It is easily, rapidly and cheaply grown in large quantities.(2) The manipulation of DNA is well defined and relatively easy.(3) There is a wide range of both plasmid and phage vectors, that
can be introduced into bacterial cells at a high efficiency.(4) Simple eukaryotic proteins can be produced in very high
yields.
Disadvantages of E. coli a host for the production of heterologous proteins :(1) Recognise eukaryotic proteins as “foreign” - therefore will
degrade them.(2) Does not carry out eukaryotic post-translational modifications -
possibly inactive protein.(3) Does not fold eukaryotic proteins correctly - possibly inactive
protein.(4) Cannot express eukaryotic genes that contain introns.
Use E. coli as your host
Consider other options
Yeast host
44
Advantages of yeast a host for the production of heterologous proteins: (1) It is easily, rapidly and cheaply grown in large quantities - but
it is eukaryotic.(2) Relatively easy to manipulate DNA, a wide range of plasmid
vectors.(3) Can do simple post-translational modifications.(4) Can fold simple proteins.(5) It has a secretory system - proteins can be secreted into the
medium - easier to purify.
Disadvantages of yeast a host for the production of heterologous proteins:(1) Yeast is a lower eukaryote. Therefore it cannot do complex
post-translational modifications - possibly inactive proteins.
(2) Inefficient at removing introns - poor expression.
Use yeast as your host
Consider other options
Mammalian cell host
45
Advantages of mammalian cell systems for the expression of proteins: (1) Eukaryotic proteins should be correctly folded, appropriately
modified - completely functional.(2) Efficient at removing introns - can use genomic genes (with
introns).(3) Wide range of plasmid and viral based vectors.
Disadvantages of mammalian cell systems for the expression of proteins:(1) Relatively difficult to grow cultured cells in large amounts, also
expensive.(2) Poor transformation efficiencies.(3) Sometimes need specific cell lines to do specialised
modifications.(4) Stringent controls required for detection of contaminants e.g.
viruses.
Use a mammalian cell system as your host
Consider other options
E. coli vectors
46
You must now choose the vector that you will use. You may choose either:
pBR322
or
λgt11
Make a note of your choice and proceed
pBR322
47pBR322
DNA multicopy plasmid
Usually used as a cloning vector
Selective markers :
- ampicillin resistance (Amp R)
- tetracycline resistance (Tet R)
BamHI
PstI
Tet RAmp R
pBR322
Return
λgt11
48
λgt11Phage
- Defective in lysis. Therefore upon induction of gene expression the products accumulate in the cell.
Marker gene, lacZ, encodes for β-galactosidase.- β-galactosidase breaks down X-gal to give a deep blue product - blue plaques.- Inactivation of β-galactosidase by insertion of DNA into the 3’end of lacZ gene - white plaques
N.B. For correct expression of the protein, the coding sequences must be inserted in the correct reading frame.
EcoRI
Lac ZReturn
Yeast vectors
49
You must now choose the vector that you will use. You may choose either:
pJP31
or
YEp213
Make a note of your choice and proceed
pJP31
50pJP31
Multicopy, DNA plasmid
Shuttle vector - bacterial and yeast origins of replication
Selective markers :
- Yeast : auxotrophic marker - LEU2 gene
- Bacteria : Ampicillin resistance (Amp R)
Secretory, expression vector PstI
EcoRI
EcoRI
EcoRI
PstI
HinDIII
pJP31ADH terminator
- factor leader
- factor promoter
Return
YEp213
51YEp213
Multicopy, DNA plasmid
Shuttle vector - bacterial and yeast origins of replication (ORI)
2 µm sequences (ORI and STB)
Selective markers :
- Yeast : auxotrophic marker - LEU2 gene (LEU2)
- Bacteria : Ampicillin resistance (Amp R)
- Bacteria : Tetracycline resistance (Tet R)
Cloning vector PstI
EcoRI
BamHIPstI
EcoRI
PstI
EcoRI
ORI STB
Tet R
Amp R
LEU2
YEp213Return
Mammalian cell vectors
52
You must now choose the vector that you will use. You may choose either:
pMAMneo
or
Amplicon
Make a note of your choice and proceed
pMAMneo
53pMAMneo
DNA plasmid, multicopy
Shuttle vector : containing
- E. coli origin of replication
- Ampicillin resistance marker (Amp R)
- SV40 origin of replication
- Selective marker : neo - confers resistance to G418
antibiotics (neo).
- Expression cassette : MMTVpromoter sequences (MMTV P),
SV40 transcription terminator and polyadenylation signal (pA)
Can express wild type genes, although you would have to remove the
gene's own transcriptional signals in order to get a high level of
expression, which is not cell specific.
N.B. lysis of the cell occurs after only a few days due to excessive
amounts of DNA - therefore only get transient expression.
See plasmid mapReturn
Amplicon
55Amplicon
Shuttle vector, containing
- E. coli origin of replication
- Ampicillin resistance marker (Amp R)
- Selective marker : dhfr gene - confers resistance to
methotrexate (MTX) in DHFR- cell lines (DHFR).
- SV40 expression cassette : promoter sequences (P), intron
(I) and splice site, transcription terminator and
polyadenylation signal (pA).
Can express wild type genes, although you would have to remove the
gene's own transcriptional signals in order to get a high level of
expression, which is not cell specific.
Prolonged exposure to increasing concentrations of MTX results in the
amplification of the vector - stable cell line with a high level of
expression.
ReturnSee plasmid map
Restriction enzymes
57
You should now have your insert DNA (either as cDNA molecules or genomic
DNA) and you should have chosen your host-vector system. The next step is to
prepare your vector DNA for ligation with the DNA fragments. You must choose
an enzyme to cut the vector where you would like to insert your foreign DNA.
Each restriction endonuclease has a specific recognition site. Some enzymes
make a simple double-stranded cut in the middle of the site - blunt end. While
others cut the two strands at different positions - staggered cut. This results in
the DNA fragments having single-stranded overhangs - sticky ends. Ligation is
more efficient if the vector and insert DNA have complementary 'sticky ends'.
Choose an enzyme
Restriction enzymes
58
Enzyme Recognition sequence Complementary ends
EcoRI (E) G'AATTC E
BamHI (B) G'GATCC Bg / S / B
PstI (P) CTGCA'G P
BglII (Bg) A'GATCT Bg / S / B
HindIII (H) A'AGCTT H
SalI (Sa) G'TCGAC Sa
Sau3A (S) 'GATC Bg / S / B
N.B. ' indicates where the cleavage site is within the recognition sequence.
Make a note of which enzymes you have used and proceed.
To review E. coli vectors click here
To review Yeast vectors click here
To review mammalian cell vectors click here
Yeast vectors
60
PstI
EcoRI
BamHIPstI
EcoRI
PstI
EcoRI
ORI STB
Tet R
Amp R
LEU2
YEp213
PstI
EcoRI
EcoRI
EcoRI
PstI
HinDIII
pJP31ADH terminator
- factor leader
- factor promoter
Return
Mammalian cell vectors
61
SalI
PstI
MMTV P
pA SV40 P
neo
pA
Amp R
pMAMneo
BglII
PstI
P
IpA
pAI
DHFR
P
Amp R
Amplicon
SV40
Return
Alkaline phosphatase
62
After your vector DNA has been cut with a restriction enzyme, it can be treated
with alkaline phosphatase. This enzyme removes the 5' phosphate groups of the
vector DNA, thus preventing its recircularization. The foreign DNA to be inserted
still has 5' phosphate groups. Therefore for the vector to efficiently recircularize
it must incorporate an insert. A control for the efficiency of the phosphatase
reaction (we will assume it is 100% in this case) is to use half the reaction in a
ligation mix with no insert DNA. If the efficiency of the phosphatase is 100%
then you would get no religation of the vector in the absence of insert DNA,
therefore you would see no colonies on your plate.
You must now prepare your insert DNA.
If you are working with cDNA click here.
If you are using genomic DNA click here.
cDNA preparation
63
Your cDNA is blunt-ended. To increase the efficiency of your ligation you will
need to add sticky ends to your cDNA. Homopolymer tailing is one way of
adding sticky ends. A homopolymer is a polymer in which all the subunits are
the same, e.g. a DNA strand can be made up entirely of dGTP, thus giving a
poly(dG) tail. The enzyme terminal deoxynucleotidyl transferase adds
nucleotides onto the 3' OH group of double-stranded molecules. A
complementary tail must also be added onto the vector DNA for ligation to
occur.
You may add sticky ends your cDNAs using either adaptors or linkers.
Note your choice, then click here.
Adaptors
64
Adaptors are short synthetic oligonucleotides. One end is blunt and the other
end is sticky. The blunt-end ligates to DNA - thus giving it sticky ends. The
sticky end sequences are complementary to the overhangs left by restriction
enzymes e.g. BamHI. A disadvantage is that the adaptors tend to stick together
- thus giving blunt ends. You must remove unincorporated adaptors before
ligation (by running down a column) otherwise ligation will be inhibited due to
excess adaptors.
Return
Linkers
65
Linkers are short synthetic double stranded DNA oligonucleotides. They are
blunt-ended. Typical linkers contain restriction sites. They are attached to the
ends of the cDNA by blunt-ended ligation (linkers are added in high
concentrations to increase the efficiency of blunt-ended ligation). To make sticky
ends, the linkers are cut with the appropriate restriction enzyme. You must
remove unincorporated linkers before ligation, by running down a column,
otherwise ligation will be inhibited due to excess linkers.
If you choose to use linkers, you must select a restriction enzyme to make sticky
ends. To review the available restriction enzymes click here.
Return
Restriction enzymes
66
Enzyme Recognition sequence Complementary ends
EcoRI (E) G'AATTC E
BamHI (B) G'GATCC Bg / S / B
PstI (P) CTGCA'G P
BglII (Bg) A'GATCT Bg / S / B
HindIII (H) A'AGCTT H
SalI (Sa) G'TCGAC Sa
Sau3A (S) 'GATC Bg / S / B
N.B. ' indicates where the cleavage site is within the recognition sequence.
Return
Genomic DNA preparation
67You have isolated cosmid DNA carrying your gene, digested with BamHI and
isolated the insert DNA. The insert DNA must now be partially digested with a
restriction enzyme which gives complementary ends to the vector DNA. The
DNA is partially digested in order to give a range of fragment sizes, and also to
overcome the risk of the gene of interest containing an internal restriction site.
Choose a restriction enzyme:Enzyme Recognition sequence Complementary ends
EcoRI (E) G'AATTC E
BamHI (B) G'GATCC Bg / S / B
PstI (P) CTGCA'G P
BglII (Bg) A'GATCT Bg / S / B
HindIII (H) A'AGCTT H
SalI (Sa) G'TCGAC Sa
Sau3A (S) 'GATC Bg / S / B
N.B. ' indicates where the cleavage site is within the recognition sequence.
Note your choice, then click here.
Ligation
68
Your vector DNA and insert DNA are ligated by the action of DNA ligase. In your
ligation mix you will have :
- unligated vector
- unligated insert DNA
- vectors recircularised without insert (if you have not
dephosphorylated your vector)
- recombinant DNA molecules
You now need to transform your E. coli with your ligation mix and then
select for recombinant molecules.
Proceed
E.coli transformation
69
cDNA and genomic libraries are usually constructed in E. coli due to the high
efficiency of transformation. During the process of transformation each bacterial
cell should only take up one DNA molecule, which is then amplified within the
cell. Consequently, the cell, once plated onto solid media, will form a colony
which will only have one type of plasmid. It is then possible to screen the
colonies to isolate the one which contains the gene of interest.
If you are using a DNA plasmid (pBR322, pJP31, YEp213, Amplicon or
pMAMneo), click here.
If you are using λgt11, click here.
70
E. coli transformation
There are two major methods of transformation :
(1) Treat bacterial cells with CaCl2, which causes the DNA to precipitate on
the surface of the bacterium. Uptake of DNA into the cell is then
stimulated by heat shock. Once you have transformed your cells with
your ligation mix you must select for recombinant plasmids.
(2) Electroporation : Bacterial, yeast and mammalian cells can be subjected
to a short electrical pulse, which allows the DNA to enter the cell. It is
thought that the electric pulse induces the transient formation of pores in
the cell membrane through which the DNA enters the cell.
Proceed
Antibiotic selection
71
Antibiotics, such as ampicillin (Amp) and tetracycline (Tet), can be added to the
solid agar media on which you plate your transformants. Cells containing a
recircularised vector (with or without an insert) will be able to grow on the
media, due to the appropriate antibiotic resistance gene carried on the vector.
To review your plasmid vector click here.
To plate onto ampicillin click here if you are using an E.coli or yeast vector or
here if you are using a mammalian vector.
To plate onto tetracycline click here.
DNA plasmids
72
SalI
PstI
MMTV P
pA SV40 P
neo
pA
Amp R
pMAMneo
BglII
PstI
P
IpA
pAI
DHFR
P
Amp R
Amplicon
SV40
PstI
EcoRI
BamHIPstI
EcoRI
PstI
EcoRI
ORI STB
Tet R
Amp R
LEU2
YEp213
PstI
EcoRI
EcoRI
EcoRI
PstI
HinDIII
pJP31ADH terminator
- factor leader
- factor promoter
BamHI
PstI
Tet RAmp R
pBR322
Return
Ampicillin selection
73
Plasmid Vectorsticky ends
Insert DNAsticky ends
Phosphatasetreated
Number ofcolonies
pBR322 PstI P yes None
PstI E /H /S /B /Bg /Sa
yes None
PstI E /H /S /B /Bg /P no 5 x 106
BamHI B /Bg / S yes 5 x 106
BamHI E /P / H yes None
BamHI B /Bg /S /E /H /P no 5 x 106
YEp213 PstI /EcoRI B /Bg /S /E /H /P yes / no None
BamHI B /Bg /S yes 5 x 106
BamHI E /P /H yes None
BamHI B /Bg /S /E /H /P no 5 x 106
pJP31 PstI /EcoRI B /Bg /S /E /H /P yes / no None
HindIII H yes 5 x 106
HindIII B /Bg /S /E /P yes None
HindIII B /Bg /S /E /P /H no 5 x 106N.B. Sticky ends for insert DNA can be obtained by cutting linker or genomic DNA with a restriction enzyme, or adding adaptors to cDNA which have suitable complementary tails. P= PstI, B= BamHI, E= EcoRI, Bg= BglII, S= Sau3A, H= HindIII, Sa= SalI
If you have plated onto ampicillin, this table will tell you the outcome so far. If you have (5x106) colonies, click here. If you have none, click here.
Ampicillin selection
74
If you have plated onto ampicillin, this table will tell you the outcome so far. If you have (5x106) colonies, click here. If you have none, click here.
Plasmid Vectorsticky ends
Insert DNAsticky ends
Phosphatasetreated
Number of colonies
pMAMneo PstI P yes None
SalI Sa yes 5 x 106
SalI B /Bg /S /E /H /P yes none
SalI B /Bg /S /E /H /P /Sa no 5 x 106
Amplicon PstI P yes None
BglII E /H /P yes None
BglII Bg /B /S yes 5 x 106
BglII Bg /B /S /E /H /P no 5 x 106
N.B. Sticky ends for insert DNA can be obtained by cutting linker or genomic DNA with a restriction enzyme, or adding adaptors to cDNA which have suitable complementary tails. P= PstI, B= BamHI, E= EcoRI, Bg= BglII, S= Sau3A, H= HindIII, Sa= SalI
Tetracycline selection
75If you have plated onto tetracycline, this table will tell you the outcome so far. If you have (5x106) colonies, click here. If you have none, click here.
Plasmid Vectorsticky ends
Insert DNAsticky ends
Phosphatasetreated
Number ofcolonies
pBR322 PstI P yes 5 x 106
PstI E /H /S /B /Bg /Sa yes None
PstI E /H /S /B /Bg /Sa/P no 5 x 106
BamHI B /Bg /S yes None
BamHI E /P /H yes None
BamHI B /Bg /S /H /E /P /Sa no 5 x 106
YEp213 PstI /EcoRI E /H /S /B /Bg /Sa /P yes / no None
BamHI B /Bg /S yes None
BamHI E /P /H yes None
BamHI E /H /S /B /Bg /Sa /P no 5 x 106
pJP31 PstI /EcoRI /HindIII E /H /S /B /Bg /Sa /P yes / no None
pMAMneo PstI /SalI Bg /B /S /H /E /P /Sa yes / no None
Amplicon PstI /BglII Bg /B /S /H /E /P /Sa yes / no None
N.B. Sticky ends for insert DNA can be obtained by cutting linker or genomic DNA with a restriction enzyme, or adding adaptors to cDNA which have suitable complementary tails. P= PstI, B= BamHI, E= EcoRI, Bg= BglII, S= Sau3A, H= HindIII, Sa= SalI
Transfection
76
There are two methods by which phage λ can be introduced into E. coli cells.
Firstly, purified phage DNA can be mixed with competent E. coli cells and DNA
uptake is induced by heat shock. Secondly, you can infect the cells with mature
phage particles, this method is more efficient. The phage particles are
produced in vitro before being added to a culture of E. coli.
Proceed
Insertional inactivation
77
If you cut your phage DNA with EcoRI and your insert DNA had
complementary ends, then your DNA should have been inserted into the lacZ
gene, thus making it inactive. Recombinants are distinguished by plating cells
onto media containing X-gal and IPTG (induces β-galactosidase); plaques
containing normal phage are blue, recombinant plaques are white.
Vectorsticky
ends
Insert DNAsticky ends
Phosphatasetreated
White plaques Blue plaques
EcoRI E yes 1 x 105 none
EcoRI P /E / H/ B /Bg /S yes none none
EcoRI E no none 1 x 105
N.B. E= EcoRI, P= PstI, H= HindIII, B= BamHI, Bg= BglII, S= Sau3A
Click here
Click here
Click here
Mini-prep
78
You have colonies / plaques on your plates. Now you would chose a random
selection of colonies and obtain plasmid DNA from each via a "mini-prep"
method. The plasmid DNA is then cut with a selection of enzymes in order to
check for inserts - this is known as restriction mapping.
(1) If you dephosphorylated your vector DNA then all your colonies will contain plasmids with inserts (assuming 100% efficient removal of 5' phosphate groups), click here.
(2) If you did not dephosphorylate your vector DNA, click here.
Failure
79
You did not get any colonies on your plates. Therefore you either :
(1) did not have the correct antibiotic resistance marker on your plasmid.
(2) disrupted an antibiotic marker with your insert, therefore the cells are
sensitive to the antibiotic in the plates. If your vector has two antibiotic
markers check your transformants on the other antibiotic plates.
(3) did not have complementary sticky ends and had dephosphorylated
your vector DNA, therefore the DNA could not religate and so was
degraded.
(4) used an enzyme that did not linearize your vector, but cut it so many
times that the chance of all the fragments joining together in the correct position
and with an insert is negligible.
Click here to try again
Ligation
80
Failure
Since you did not dephosphorylate your vector DNA then a large proportion of
your clones contain plasmid which has recircularized without an insert. Therefore
you do not have a representative library.
Click here to try again
Screening
81
You have a representative library. Now you must screen your library for your
specific gene.
You may use either:
Colony hybridization
or
Immunological screening
Colony hybridization
82
If you know the amino acid sequence of your protein then it is possible to
synthesis a DNA oligonucleotide which corresponds to that sequence. The
oligonucleotide, which is radiolabelled, can then be used as a probe to screen
for the gene. Firstly the colonies are replica plated onto nitrocellulose filters. The
colonies are then treated so that the cell walls are broken down and the DNA,
which is made single-stranded, is bound to the filter. The filters are then
incubated with the radiolabelled oligonucleotide. The radioactive oligo will bind
to its complementary sequences, whilst all unbound oligo will be washed off.
The filter is then exposed to x-ray film and the bound oligo will indicate which
colony contains the plasmid with the correct insert.
To learn more about colony hybridization click here or here.
To use colony hybridization, click here.
To consider immunological screening click here.
Immunological screening
83
You must now identify your specific gene. The protein coded by the gene can be
detected by immunological screening. Antibodies specific for your protein are
obtained by injecting the protein into the bloodstream of a rabbit. The immune
system of the rabbit will synthesise antibodies that bind to the protein, which are
then purified from the blood. The colonies obtained from your transformation are
transferred to a membrane, lysed and then incubated with your specific antibody
which can be detected using a second antibody linked to an enzyme, for
example alkaline phosphatase. The colonies which contain your protein will then
be identified by an enzyme-catalysed reaction where a colourless substrate
gives rise to a coloured product.
To learn more about immunological screening click here.
To use immunological screening click here.
To consider colony hybridization click here.
Colony hybridization
84
If you used cDNA and obtained your mRNA from cells that synthesise your
protein (for somatostatin, pancreatic islets, for Factor IX, liver hepatocytes and
for hEGF, duodenal cells) you have a very high probability of identifying your
gene, click here. If you obtained mRNA from any other source you have a low
chance of success, click here. If you used genomic DNA previously isolated in a
cosmid vector you have a high chance of success of finding somatostatin, click
here, but the genes encoding EGF and Factor IX are too large to be cloned in E.
coli intact so you must clone via cDNA, click here.
Gene expression
85You have now isolated your gene of interest. You must now check the
expression of the gene. Yeast or mammalian expression vectors, carrying the
gene, will need to be transformed into the appropriate host strain.
N.B. (1) Many eukaryotic genes will have signal sequences at the 5' end of the
gene. which are required to target the protein for secretion. These sequences
need to be proteolytically cleaved to give an active protein. Usually when using
E. coli or yeast hosts, the signal sequence is cleaved in vitro and the host's
own signal sequences are added.
N.B. (2) If you have used genomic DNA to obtain your gene, then you will
need to sequence the DNA to identify the 5' transcriptional start sequences.
These are removed, so that the gene will be transcribed under the control of
the vector promoter sequences found on expression vectors. This ensures a
high level of expression, which is not cell specific.
E. coli vector, check expression.
Yeast vector, transform into yeast.
Mammalian vector, transfect into mammalian cell line.
Immunological screening
86
Check table to see if your gene is identified by immunological screening:
Vector Signal ?
pBR322 no
lgt11, cDNA yes
lgt11, genomic DNA no
YEp213 no
pJP31 no
pMAMneo no
amplicon no
If you have a signal, click here.
If you do not have a signal, click here.
Protein not expressed
87You have no positive signals on your autoradiograph which indicates that your
protein is not expressed. Reasons for this are :
(1) You have cloned your gene into pBR322 or YEp213. Both of these vectors
are cloning vectors and not expression vectors and therefore your gene will not
be expressed. You must choose an expression vector. Click here to choose an
E.coli vector or here to choose a yeast vector.
(2) You have used a mammalian or yeast expression vector. These
expression signals will not work in E. coli, therefore you must isolate your
gene by colony hybridization. Click here.
(3) You have cloned genomic DNA into the λgt11 E. coli vector. Since E. coli
cannot remove introns, the gene is not expressed correctly. You must an
alternative host. Click here.
Yeast transformation
88
There are a number of different methods of transforming yeast cells. For
example, yeast cells can be made competent for DNA uptake by treatment with
lithium acetate. Then in the presence of a carrier DNA and polyethylene glycol
the DNA is taken up into the cell after heat shock treatment. Yeast cells can
also be transformed by electroporation.
Complementation selection of plasmid containing cells is then performed. Yeast
plasmids usually carry an auxotrophic marker gene, in this case the LEU2
gene. The yeast strain you have transformed requires leucine for growth since
it has a mutant leu2 gene. Therefore only cells which have plasmids will be
able to grow on leucine free media.
Proceed
Mammalian cell transfection
89
There are a number of methods for transfecting mammalian cells. A commonly
used method is calcium phosphate co-precipitation. DNA is mixed with a
carefully buffered solution containing phosphate. Addition of CaCl2 results in the
formation of a fine precipitate of CaPO4 and DNA. The precipitate is pipetted
onto a monolayer of cells growing in a petri-dish and left on the cells for several
hours, during which time 10-1-10-4 cells take up DNA. The precipitate is then
removed from the cells, which are then incubated in fresh media for 30-48 hrs
transient expression. While incubation in selective media for 10-14 days stable
expression. It is also possible to transfect mammalian cell by electroporation.
Before going ahead with the transfection procedure you must choose a cell line.
Click here.
Mammalian cell lines
90
Some proteins require specialised post-translational modifications which are
specific to certain cell types. Therefore if you tried to express these proteins in
other cell lines the resultant proteins would be inactive.
You must choose the cell line appropriate for the expression of your protein.
(1) hepatic cell line
(2) fibroblast cell line
(please note which cell line you have used)
After transfection you must select for cells which have taken up DNA. Click here.
Cell selection
91
There are two methods of selecting for plasmid-containing cells, dependent on the
plasmid marker used.
(1) pMAMneo carries the neo marker gene, which confers resistance
against the antibiotic G418. Therefore :
- mammalian cells plus plasmid (neo) will grow in the presence of
G418.
- mammalian cells minus plasmid (neo) will not grow in presence of
G418.
(2) Amplicon carries a dhfr gene which confers resistance to the drug,
methotrexate (MTX). Therefore if you are using a mammalian cell line
which does not have a DHFR gene:
- mammalian cells plus plasmid (dhfr) will grow in the presence of
MTX.
- mammalian cells minus plasmid (dhfr) will not grow in presence of
MTX.
Proceed
Summary
92
You have now transformed your vector, which carries your gene of interest, into the appropriate host strain, and identified plasmid-containing colonies.
You must now check that the protein is expressed. Click here.
Western blotting
93
Western blotting can be used to detect the expression of a protein. A total
protein extract is obtained from a transformed cell. The proteins are then
separated by polyacrylamide gel electrophoresis. The proteins from the gel are
then transferred to a membrane and then probed with a labelled antibody
specific to that protein. Western blotting can also establish whether the protein
expressed is of the correct length.
Check the expression of your protein :
If using E. coli - Click here
If using yeast - Click here
If using mammalian cells - Click here
Summary
94
You have cloned your gene into a λ expression vector, which should give you a
fusion protein of β-galactosidase and your protein. You will have to cleave the
fusion protein with cyanogen bromide in order to remove the β-galactosidase
part of the fusion protein.
Check the table to see if you have expressed a protein.
Plasmid Enzyme site Insert DNA Protein Expression ? Go to
pBR322 PstI /BamHI cDNA / genomic Any no 100
lgt11 EcoRI cDNA Somatostatin yes 95
hEGF yes 95
Factor IX yes 95
lgt11 EcoRI genomic Somatostatin no 100
Active protein?
95
Recombinant proteins are tested to see if they are biologically active by a
number of means dependent on the type of protein. For example, Factor IX
protein activity is determined by a blood clotting assay. EGF activity is
determined by a competitive receptor binding assay.
Check table to see if your protein is biologically active.
Plasmid Enzyme site Insert DNA Protein Active ? Go to:
lgt11 EcoRI cDNA Somatostatin yes 102
hEGF no 101
Factor IX no 101
genomic Somatostatin yes 102
Summary
96
You have cloned your gene into a yeast expression vector.
Check the table to see if you have expressed a protein.
Plasmid Enzyme site Insert DNA Protein Expression ? Go to:
YEp213 BamHI cDNA / genomic Any no 100
pJP31 HindIII cDNA Somatostatin yes 97
hEGF yes 97
Factor IX yes 97
pJP31 HindIII genomic Somatostatin yes 97
Active protein?
97
Recombinant proteins are tested to see if they are biologically active by a number of means dependent on the type of protein. For example, Factor IX protein activity is determined by a blood clotting assay. Whereas EGF activity is determined by a competitive receptor binding assay. Check table to see if your protein is biologically active.
Plasmid Insert DNA Protein Active ? Go to
pJP31 cDNA Somatostatin yes 102
pJP31 cDNA hEGF yes 102
pJP31 cDNA Factor IX no 101
pJP31 genomic Somatostatin yes 102
Summary
98
You have expression of all proteins (somatostatin, EGF and Factor IX), in all cell
lines used (hepatic and fibroblast). You must now check biological activity. Click
here.
Active protein?
99
Plasmid Protein Cell line Activity Go to
pMAMneo Somatostatin hepatic transient 102
hEGF transient 102
Factor IX transient 102
pMAMneo Somatostatin fibroblast transient 102
hEGF transient 102
Factor IX no 101
Amplicon Somatostatin hepatic stable 102
hEGF stable 102
Factor IX stable 102
Amplicon Somatostatin fibroblast stable 102
hEGF stable 102
Factor IX no 101
N.B. (1) Transient expression - due to high level of DNA in cell, the cell lyses after a few days, therefore the recombinant protein is only expressed at a high level for a few days.N.B. (2) Stable expression - recombinant DNA integrates into the genome, therefore there is stable expression of the protein.
Failure
100You have not been able to express your gene in this host - vector system. The
reasons for this are :
(1) You have cloned into pBR322 or YEp213. These are cloning vectors
which have no expression signals.
(2) Also the insert DNA does not have any expression signals therefore
there is no expression of the protein.
You must go back and choose another host or expression vector
- Click here.
N.B. Another possible reason for the absence of expression is that the
gene may have been inserted into the vector in the incorrect orientation,
therefore is unable to use the vectors promoter sequences. If the sequence or
restriction map of the gene is known then restriction mapping can be used to
determine whether this is the case.
Failure
101You have managed to express your protein but it is not biologically active
therefore can not be used for medical purposes. There are a number of possible
reasons why your protein is inactive.
For example:
(1) You have expressed hEGF or Factor IX in E. coli. Both these
proteins require post- translational modifications for them to be active - E. coli
cannot do these post-translational modifications hence they are inactive. You
need to choose a different host system - Click here
(2) You have expressed Factor IX in yeast. Factor IX is a very complex
protein which requires a number of post -translational modifications which are
specific to mammalian hepatic cells. Yeast can only do simple post-translational
modifications, thus Factor IX is inactive when expressed in yeast. You need to
choose a different host system. - Click here
(3) You have expressed your Factor IX in a non-hepatic cell line.
Therefore, the protein is not processed correctly. - Click here
Success
102
Well done !!!! You have successfully produced your protein and it is
biologically active.
Producing a cell that synthesises large amounts of a desired protein is only the
first stage in achieving a useful process. It is important to be able to recover the
protein by a simple, economical method that results in high yields of a
biologically active protein. Cell cultures can be scaled up and grown in large
fermentors, and then the protein can be purified using a number of methods.